Aims and scope
Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. The journal covers a broad spectrum of preeminent practices and best available data to the top interventional and translational research, and innovative developments in the field of infection control.
Antimicrobial Resistance and Infection Control believes that future solutions require a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, possibilities to prevent transmission and infection, and insight into the difference between developed countries and countries with limited resources. Antimicrobial Resistance and Infection Control needs to combine best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. ARIC welcomes all manuscripts related to the field of HAI prevention and infection control. Some examples are listed below:
- Prevention of health-care associated infection in hospitals.
- Infection control and antimicrobial-resistance in high-risk settings (e.g. ICUs).
- HAI prevention and antimicrobial-resistance in special settings e.g. long-term care facilities.
- Infection control and antimicrobial-resistance in community settings.
- Special problems with infection control and antimicrobial-resistance in resource-limited countries.
ARIC is proud to be affiliated with several societies that support and promote the work done in our field.
The International Conference for Prevention and Infection Control (ICPIC) is a unique platform to foster knowledge sharing and exchange experiences for the prevention of healthcare-associated infection and the control of antimicrobial resistance among countries around the world. To achieve this aim and to ensure a global dialogue, ICPIC encourages and facilitates the attendance of many fellows from nations with limited resources, notably from the African region.
The Asia Pacific Society of Infection Control (APSIC) was established in 1998 and is a multi-national, voluntary organization dedicated to the advancement of infection control practice to reduce hospital associated infections, monitor and control emerging and re-emerging infectious diseases and improved patient outcomes. APSIC aims to bring together multidisciplinary infection control professionals in the region to share their knowledge, experience, skills, and quality improvement and research findings by facilitating the exchange of information through training courses, seminars, congresses and conferences in the Asia Pacific region.
The Infection Control Africa Network (ICAN) is an organization that promotes collaboration between individuals and institutions working in the field of infection control in Africa. The network currently has over 300 members from 24 African countries, and is led by an enthusiastic board of multi-national leaders in infection control. The vision of ICAN is an African continent where safe patient care is ensured for all through the implementation of strong infection control programs. ICAN has several active working groups dedicated to reducing healthcare associated infection and promoting antimicrobial stewardship on the continent, including education, communication, surveillance and community participation committees.
All articles published by Antimicrobial Resistance & Infection Control are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Antimicrobial Resistance & Infection Control you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Antimicrobial Resistance & Infection Control therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Antimicrobial Resistance & Infection Control are included in:
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Antimicrobial Resistance & Infection Control has an Impact Factor of 2.716.
Antimicrobial Resistance & Infection Control operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Antimicrobial Resistance & Infection Control should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Antimicrobial Resistance & Infection Control
Articles in Antimicrobial Resistance & Infection Control should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Antimicrob Resist Infect Control [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Antimicrob Resist Infect Control 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Antimicrobial Resistance & Infection Control
Antimicrobial Resistance & Infection Control's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Antimicrobial Resistance & Infection Control offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Antimicrobial Resistance & Infection Control gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Antimicrobial Resistance & Infection Control are included in article alerts and regular email updates. Some may be highlighted on Antimicrobial Resistance & Infection Control’s pages and on the BioMed Central homepage.
In addition, articles published in Antimicrobial Resistance & Infection Control may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Antimicrobial Resistance & Infection Control. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Antimicrobial Resistance & Infection Control you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.